Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNOPSYS INC Director's Dealing 2019

Dec 16, 2019

29855_dirs_2019-12-16_02f1b6be-fe7a-406b-9e1f-bc7b56f484c3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2019-12-12

Reporting Person: CHAN CHI-FOON (Director, Co-CEO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-12 Common Stock M 6197 $0.0 Acquired 212395 Direct
2019-12-12 Common Stock F 3073 $135.88 Disposed 209322 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-12 Non-Qualified Stock Option (right to buy) $135.88 A 74641 Acquired 2026-12-12 Common Stock (74641) Direct
2019-12-12 Restricted Stock Units $0.0 A 24788 Acquired 2022-12-08 Common Stock (24788) Direct
2019-12-12 Restricted Stock Units $0.0 D 6197 Disposed 2022-12-08 Common Stock (6197) Direct

Footnotes

F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award holder in connection with the vesting of an installment of the performance restricted stock unit award. The Compensation Committee approved the disposition of shares by the award holder and the amount retained by the Company was not in excess of the amount of the tax liability.

F2: Grant to reporting person to buy shares of common stock under the Synopsys, Inc 2006 Employee Equity Incentive Plan. The Compensation Committee of the Board of Directors approved an option grant value of $2,300,000, with the number of shares subject to the option to be determined by dividing that amount by the fair value of an option to acquire a share of Synopsys common stock on the grant date using the Black-Scholes option pricing model.

F3: 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter.

F4: On 12/12/18 the Compensation Committee of the Board of Directors approved a Restricted Stock Unit grant value of $2,225,000, with the number of granted Restricted Stock Units to be determined by dividing that amount by the closing price of Synopsys common stock on the grant date. The vesting of such Restricted Stock Units was based on satisfaction of certain performance criteria for the fiscal year ending 11/02/19. The performance criteria were met.

F5: 25% of the units vest on the date shown followed by three equal annual installments.